Cargando…

The Clinicopathologic and Prognostic Value of Altered Chromosome 17 Centromere Copy Number in HER2 Fish Equivocal Breast Carcinomas

Chromosome 17 centromere (CEP17) gain is frequently observed in breast cancer by fluorescence in situ hybridization (FISH). To address the biologic characteristics and clinical significance of CEP17 gain in a large population of breast cancer patients, we performed FISH on a series of 770 breast can...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ji, Hongfei, Xuan, Qijia, Nanding, Abiyasi, Zhang, Haiyu, Zhang, Qingyuan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4498752/ https://www.ncbi.nlm.nih.gov/pubmed/26161550 http://dx.doi.org/10.1371/journal.pone.0132824

Ejemplares similares

The prognostic and predictive value of the lymphocyte to monocyte ratio in luminal-type breast cancer patients treated with CEF chemotherapy
por: Ji, Hongfei, et al.
Publicado: (2016)

Clinical array-based karyotyping of breast cancer with equivocal HER2 status resolves gene copy number and reveals chromosome 17 complexity
por: Gunn, Shelly, et al.
Publicado: (2010)

Centromere 17 copy number gain reflects chromosomal instability in breast cancer
por: Lee, Kyoungyul, et al.
Publicado: (2019)

Expression and Prognostic Value of Glucose Transporter 3 in Diffuse Large B Cell Lymphoma
por: Xu, Yongpeng, et al.
Publicado: (2022)

Unraveling the chromosome 17 patterns of FISH in interphase nuclei: an in-depth analysis of the HER2 amplicon and chromosome 17 centromere by karyotyping, FISH and M-FISH in breast cancer cells
por: Rondón-Lagos, Milena, et al.
Publicado: (2014)

Immunohistochemistry and alternative FISH testing in breast cancer with HER2 equivocal amplification
por: Agersborg, Sally, et al.
Publicado: (2018)

Impact of chromosome 17 centromere copy number increase on patient survival and human epidermal growth factor receptor 2 expression in gastric adenocarcinoma
por: Ciesielski, Maciej, et al.
Publicado: (2021)

Chromosome 17 copy number changes in male breast cancer
por: Lacle, Miangela M., et al.
Publicado: (2015)

Clinicopathological Features and Prognosis of Papillary Thyroid Microcarcinoma for Surgery and Relationships with the BRAF(V600E) Mutational Status and Expression of Angiogenic Factors
por: Shi, Chenlei, et al.
Publicado: (2016)

Assessment of ERBB2/HER2 Status in HER2-Equivocal Breast Cancers by FISH and 2013/2014 ASCO-CAP Guidelines
por: Press, Michael F., et al.
Publicado: (2018)

Characteristics of HER2-negative breast cancers with FISH-equivocal status according to 2018 ASCO/CAP guideline
por: Kong, Hui, et al.
Publicado: (2022)

Rate of reclassification of HER2-equivocal breast cancer cases to HER2-negative per the 2018 ASCO/CAP guidelines and response of HER2-equivocal cases to anti-HER2 therapy
por: Crespo, James, et al.
Publicado: (2020)

The frequency and clinical significance of centromere enumeration probe 17 alterations in human epidermal growth factor receptor 2 immunohistochemistry‐equivocal invasive breast cancer
por: Katayama, Ayaka, et al.
Publicado: (2022)

Development of automated brightfield double In Situ hybridization (BDISH) application for HER2 gene and chromosome 17 centromere (CEN 17) for breast carcinomas and an assay performance comparison to manual dual color HER2 fluorescence In Situ hybridization (FISH)
por: Nitta, Hiroaki, et al.
Publicado: (2008)

The Equivocal Role of Th17 Cells and Neutrophils on Immunopathogenesis of Leishmaniasis
por: Gonçalves-de-Albuquerque, Suênia da C., et al.
Publicado: (2017)

Evaluation of chromosome 17 polysomy in breast cancer by FISH analysis of whole nuclei, and its clinicopathological significance
por: JIANG, HUIYONG, et al.
Publicado: (2014)

Robust and accurate digital measurement for HER2 amplification in HER2 equivocal breast cancer diagnosis
por: Wang, Yuefeng, et al.
Publicado: (2017)

Analysis of 17 Prenatal Cases with the Chromosomal 1q21.1 Copy Number Variation
por: Wen, Xiaohui, et al.
Publicado: (2022)

A clinicopathological study and survival analysis of 99 breast cancers with HER2/CEP17 ratio ≥ 2.0 and an average HER2 copy number < 4.0 per cell in China
por: Zhou, Shuling, et al.
Publicado: (2023)

Classification of HER2-negative breast cancers by ERBB2 copy number alteration status reveals molecular differences associated with chromosome 17 gene aberrations
por: Loh, Jui Wan, et al.
Publicado: (2023)

The Dilemma of HER2 Double-equivocal Breast Carcinomas: Genomic Profiling and Implications for Treatment
por: Marchiò, Caterina, et al.
Publicado: (2018)

PCR amplicons identify widespread copy number variation in human centromeric arrays and instability in cancer
por: de Lima, Leonardo Gomes, et al.
Publicado: (2021)

Multiplication of Chromosome 17 Centromere Is Associated with Prognosis in Patients with Invasive Breast Cancers Exhibiting Normal HER2 and TOP2A Status
por: Kim, Aeri, et al.
Publicado: (2012)

Insulinoma with equivocal imaging
por: Belabed, Wafa, et al.
Publicado: (2023)

Evaluation of Immunohistochemistry-Equivocal (2+) HER2 Gene Status in Invasive Breast Cancer by Silver DNA in Situ Hybridization (SISH) and its Association with Clinicopathological Variables
por: A. Musa, Zaidoon, et al.
Publicado: (2017)

Cell cycle and centromere FISH studies in premature centromere division
por: Corona-Rivera, Alfredo, et al.
Publicado: (2005)

Evaluation of ERBB2 mRNA Expression in HER2-Equivocal (2+) Immunohistochemistry Cases
por: Carretero-Barrio, Irene, et al.
Publicado: (2023)

The Role of Number of Copies, Structure, Behavior and Copy Number Variations (CNV) of the Y Chromosome in Male Infertility
por: Signore, Fabrizio, et al.
Publicado: (2019)

The overexpression of MDM4: an effective and novel predictor of gastric adenocarcinoma lymph node metastasis
por: Bao, Junjie, et al.
Publicado: (2016)

Focus on the Predictive Value of Subclassification of Extratumoral Structural Abnormalities for Malignant Nonspiculate and Noncalcified Masses on Digital Mammography
por: Xu, Ye, et al.
Publicado: (2022)

Equivocal associations between small‐scale shoreline restoration and subtidal fishes in an urban estuary
por: Francis, Tessa B., et al.
Publicado: (2022)

HER2 copy number as predictor of disease-free survival in HER2-positive resectable gastric adenocarcinoma
por: Liu, Zimin, et al.
Publicado: (2021)

Chromosome 17 Centromere Duplication and Responsiveness to Anthracycline-Based Neoadjuvant Chemotherapy in Breast Cancer()()
por: Tibau, Ariadna, et al.
Publicado: (2014)

Correlation of EGFR expression, gene copy number and clinicopathological status in NSCLC
por: Gaber, Rania, et al.
Publicado: (2014)

Breast Cancer With a HER2 IHC2+ and FISH HER2/CEP17 Ratio ≥2.0 and an Average HER2 Gene Copy Number <4.0 per Tumor Cell: HER2 mRNA Overexpression Is a Rare Event
por: Liu, Yuanyuan, et al.
Publicado: (2020)

Observations in Support of Equivocal Generation
Publicado: (1811)

Association of HER-2/CEP17 Ratio and HER-2 Copy Number With pCR Rate in HER-2-Positive Breast Cancer After Dual-Target Neoadjuvant Therapy With Trastuzumab and Pertuzumab
por: Li, Fanfan, et al.
Publicado: (2022)

Chromosome Y Centromere Array Deletion Leads to Impaired Centromere Function
por: Graham, Alison N., et al.
Publicado: (2014)

The effect of an alternative chromosome 17 probe on fluorescence in situ hybridization for the assessment of HER2 amplification in invasive breast cancer
por: Xu, Zhigao, et al.
Publicado: (2019)

Recurrent Chromosomal Copy Number Alterations in Sporadic Chordomas
por: Le, Long Phi, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_7s2971u27aramfrkul81d8vg7h